| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T92 |
0-10 |
Sentence |
denotes |
Patient 3: |
| T93 |
11-119 |
Sentence |
denotes |
An 81-year old female, who is COVID-19 positive contact was not identified at the moment of hospitalization. |
| T94 |
120-278 |
Sentence |
denotes |
She started symptoms on 2 April and entered the ICU on 5 April. Patient has a previous history of hypertension, diabetes mellitus, glaucoma and smoking habit. |
| T95 |
279-339 |
Sentence |
denotes |
She was admitted with frequent cough, wheezing and diarrhea. |
| T96 |
340-420 |
Sentence |
denotes |
The diagnosis of viral pneumonia by COVID-19 was confirmed by RT-PCR on 7 April. |
| T97 |
421-539 |
Sentence |
denotes |
Oxygen support at 5 l/min and treatment with ceftriaxone, lopinavir–ritonavir, chloroquine and IFN α-2b was indicated. |
| T98 |
540-610 |
Sentence |
denotes |
Chest images showed bilateral interstitial infiltration in both lungs. |
| T99 |
611-716 |
Sentence |
denotes |
Patient condition was classified as severe, although she did not require invasive mechanical ventilation. |
| T100 |
717-798 |
Sentence |
denotes |
A dose of itolizumab (200 mg) was given the day after her admission into the ICU. |
| T101 |
799-1045 |
Sentence |
denotes |
Two days after the antibody administration, together with the rest of the therapy, there was an improvement of the respiratory distress while the chest image showed a decrease of the alveolar interstitial infiltrate of both lungs (Figure 1C & D). |
| T102 |
1046-1121 |
Sentence |
denotes |
Patient left the ICU after a favorable clinical and radiological evolution. |
| T103 |
1122-1198 |
Sentence |
denotes |
IL-6 concentration was measured prior and after the antibody administration. |
| T104 |
1199-1374 |
Sentence |
denotes |
IL-6 level at baseline was lower than in previous cases (30 pg/ml), but also decreased 48 h and 168 h after itolizumab infusion, in parallel with patient recovery (Figure 2A). |
| T105 |
1375-1457 |
Sentence |
denotes |
IL-1 and TNF-α were untraceable before and 48 h after the antibody administration. |
| T106 |
1458-1566 |
Sentence |
denotes |
Regarding to AST concentration, the values were in the normal range during the treatment period (Figure 2B). |